-
biomedical engineer, materials scientist, immunologist, or cancer biologist who can help us develop new minimally invasive cancer therapies, such as new materials or devices for drug delivery into tumors
-
labs involved in cutting edge technology, research, and clinical immunotherapeutic programs. Dr. Lior Goldberg’s lab currently has an opening for a Postdoctoral Fellow who will develop chimeric antigen
-
complex biology research experiments. As a successful candidate, you will: Characterize engineered natural killer (NK) cells and patient samples. Possess pathology knowledge and proficiency in various
-
clinical setting Your qualifications should include: · Ph.D. degree chemistry, biochemistry, structural biology, biophysics or a related discipline is required. · Knowledge of protein engineering
-
technology and contribute to groundbreaking discoveries in cancer and related diseases. For more information on Dr. Saul Priceman’s research, please visit here . As a successful candidate, you will: Conduct
-
labs involved in cutting edge technology, research, and clinical immunotherapeutic programs. Dr. Lior Goldberg’s lab currently has an opening for a Postdoctoral Fellow who will develop chimeric antigen
-
specific to the RefleXion linear accelerator. RefleXion is a novel radiation machine that delivers treatment using positron emission tomography (PET) guidance. As it is a new technology and our program is
-
edge technology, research and clinical immunotherapeutic programs. New personnel will be trained in project specific techniques and procedures. As a successful candidate, you will: · Manufacture
-
edge technology, research and clinical immunotherapeutic programs. New personnel will be trained in project specific techniques and procedures. As a successful candidate, you will: · Manufacture
-
-paced lab involved in cutting edge technology, research and clinical immunotherapeutic programs. New personnel will be trained in project specific techniques and procedures. As a successful candidate